the next phase is GLP next month and that’s de risked then onto Walter Reed results announcement and phase 1 results at the same time. Its de risked on both those studies. It is the next AGN which again trading north of 100 million market cap. It’s coming
This drug has been researched and developed over 8 years. 8 years of millions of dollars of research and now starts the show and it’s a 10 million market cap with 10 million in funding. Yeh it’s game on
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-160
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.028(32.2%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $296.2K | 2.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 175032 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |